[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR066268A1 - Compuesto de imidazol sustituido y su uso - Google Patents

Compuesto de imidazol sustituido y su uso

Info

Publication number
AR066268A1
AR066268A1 ARP080101712A ARP080101712A AR066268A1 AR 066268 A1 AR066268 A1 AR 066268A1 AR P080101712 A ARP080101712 A AR P080101712A AR P080101712 A ARP080101712 A AR P080101712A AR 066268 A1 AR066268 A1 AR 066268A1
Authority
AR
Argentina
Prior art keywords
substituents
optionally
imidazol
hypertension
alkyl
Prior art date
Application number
ARP080101712A
Other languages
English (en)
Inventor
Naohiro Taya
Kouichi Iwanaga
Tsuneo Oda
Yasutomi Asano
Hidekazu Tokuhara
Yoshiyuki Fukase
Takanobu Kuroita
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of AR066268A1 publication Critical patent/AR066268A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuesto de la presente tiene una actividad inhibidora de renina superior, y, así, es de utilidad como un agente para la prevencion o el tratamiento de hipertension, diversos danos orgánicos atribuibles a hipertension, y similares Reivindicacion1: Un compuesto caracterizado por la formula: 1 en donde R1 es un sustituyente, R2 es un grupo cíclico que opcionalmente tiene sustituyentes, alquilo C1-10 que opcionalmente tiene sustituyentes, alquenilo C2-10 que opcionalmente tiene sustituyenteso alquinilo C2-10 que opcionalmente tiene sustituyentes, R3 es un átomo de hidrogeno, un átomo de halogeno, alquilo C1-6 o alcoxi C1-6, X es enlace o espaciador que tiene 1 a 6 átomos en la cadena principal, anillo A es cicloalcano C5-7 queopcionalmente tiene sustituyentes, y anillo B es piperazina que también tiene opcionalmente sustituyentes además de R1, o una de sus sales.
ARP080101712A 2007-04-27 2008-04-23 Compuesto de imidazol sustituido y su uso AR066268A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007120292 2007-04-27
JP2007207271 2007-08-08

Publications (1)

Publication Number Publication Date
AR066268A1 true AR066268A1 (es) 2009-08-05

Family

ID=39657370

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080101712A AR066268A1 (es) 2007-04-27 2008-04-23 Compuesto de imidazol sustituido y su uso

Country Status (6)

Country Link
US (1) US20090156612A1 (es)
AR (1) AR066268A1 (es)
CL (1) CL2008001163A1 (es)
PE (1) PE20090243A1 (es)
TW (1) TW200904433A (es)
WO (1) WO2008139941A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009051112A1 (ja) * 2007-10-15 2009-04-23 Takeda Pharmaceutical Company Limited アミド化合物およびその用途
JP4800445B2 (ja) 2008-06-19 2011-10-26 武田薬品工業株式会社 複素環化合物およびその用途
AR079967A1 (es) 2010-01-26 2012-02-29 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos con oxigeno y su uso como productos farmaceuticos
US20120178813A1 (en) 2011-01-12 2012-07-12 Thetis Pharmaceuticals Llc Lipid-lowering antidiabetic agent
US8765811B2 (en) 2012-07-10 2014-07-01 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US9382187B2 (en) 2012-07-10 2016-07-05 Thetis Pharmaceuticals Llc Tri-salt form of metformin
WO2015171516A1 (en) 2014-05-05 2015-11-12 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
KR20170023061A (ko) 2014-06-18 2017-03-02 테티스 파마수티컬스 엘엘씨 활성제의 미네랄 아미노산 복합체
US9242008B2 (en) 2014-06-18 2016-01-26 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of fatty acids
CA3026264A1 (en) 2016-06-03 2017-12-07 Thetis Pharmaceuticals Llc Compositions and methods relating to salts of specialized pro-resolving mediators
CA3101277A1 (en) 2018-05-24 2019-11-28 3M Innovative Properties Company N-1 branched cycloalkyl substituted imidazo[4,5-c]quinoline compounds, compositions, and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
JP2009526747A (ja) * 2006-02-16 2009-07-23 武田薬品工業株式会社 環状アミン化合物および高血圧の予防・治療のための用途

Also Published As

Publication number Publication date
WO2008139941A1 (en) 2008-11-20
TW200904433A (en) 2009-02-01
PE20090243A1 (es) 2009-04-03
CL2008001163A1 (es) 2008-12-19
US20090156612A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
AR066268A1 (es) Compuesto de imidazol sustituido y su uso
DOP2013000123A (es) Compuesto heterocíclico y su uso.
RS53688B1 (en) 1,2,5-OXADIAZOLES AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS
AR070479A1 (es) Derivado heterociclico fusionado y su uso
DOP2010000183A (es) Derivados de itazol usados como inhibidores de pi 3-cinasa
CR9830A (es) Compuestos de amino-5-[4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de la b-secretasa
ECSP11010912A (es) Compuestos de pirrol
CO6300939A2 (es) Compuestos novedosos que son inhibidores de erk referencia a una solicitud relacionada
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
SMAP201100019A (it) Composti organici.
ATE542798T1 (de) Organische verbindungen
CO6341581A2 (es) Derivados de heteroarilo como inhibidores de dgat1
DK2074120T3 (da) Tropan-forbindelser
AR084011A1 (es) Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen
PA8793201A1 (es) Pirimidinas bicíclicas fusinadas
MX368178B (es) Compuestos de ácido dimetilbenzoico.
RS52520B (en) ACT AND P70 S6 KINASE INHIBITORS
CR11859A (es) Composición y proceso-356
AR081819A1 (es) Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades
RS51190B (sr) Aminoacilni derivati kao prolekovi i lekovi za lečenje tromboembolijskih bolesti
CR11860A (es) Derivados de dibenzotiazepina y sus usos - 424
ATE481395T1 (de) Cyclohexylderivate
BRPI0921059A2 (pt) derivados de bifenilacetamida
ATE455533T1 (de) Benzimidazole als kühlende verbindungen
AR086555A1 (es) Antagonistas de p2x7r y su uso

Legal Events

Date Code Title Description
FB Suspension of granting procedure